Glyukokortikosteroidnye gormony - «zolotoy» standart v lechenii bol'nykh bronkhial'noy astmoy
- Authors: Trofimov V.I1
-
Affiliations:
- Issue: No 4 (2015)
- Pages: 61-64
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/287773
- ID: 287773
Cite item
Open Access
Access granted
Abstract
This paper reviews the role of glucocorticoids in the treatment of patients with bronchial asthma. Cellular and molecular mechanisms of anti-inflammatory action of glucocorticoids are discussed. Systemic and inhaled corticosteroids are presented as a means of achieving and maintaining asthma control. A variety of corticosteroid medications for asthma, as well as devices for delivery of inhaled corticosteroid formulations are compared. Efficient regimens of systemic and inhaled corticosteroids administration are presented.
Full Text
References
- Global Initiative for Asthma. Global strategy for Asthma Management and Prevention. Revised. 2014. www.ginasthma.org
- Barnes P.J., Adcock J.M. How Do Corticosteroids Work in Asthma? Ann. Intern. Med. 2003;139:359-70.
- Schwiebert L.M., Stellato C, Schleimer R.P. The epithelium as a target of glucocorticoid action in the treatment of Asthma. Am. J. Respir. Crit. Care Med. 1996;154: 16-20.
- Barnes P.J. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 2013;131:636-45.
- Hubner M., Hochhaus G., Derendorf H. Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticoids. Immunol. Allergy Clin. North. Am. 2005;25:469-88.
- Ненашева Н.М. Безопасность ингаляционных глюкокортикостероидов в терапии бронхиальной астмы. Пульмонология. 2014;3:113-20.
- Padden J., Sconer D., Hochhaus G. Pharmacokinetics, and pharmacodynamics of inhaled glucocorticoids. J. Asthma. 2006;45(1):13-24.
- Трофимов В.И. Циклесонид в лечении больных бронхиальной астмой. Медицинский твет. 2014;16:32-4.
- Бернс П., Годфри С. Бронхиальная астма. М.: Бином, 2003. 125 с.
- Ahmet A., Kim H., Spie S. Adrenal suppression: a practical guide to the screening and management of this under-recognise complication of inhaled corticosteroid therapy. Allergy Asthma Clin. Immunol. 2013;7:13. doi: 10.1186/17101492-7-13.
- Buehring B., Viswanthem R., Binkley N., Busse W. Glukocorticoid-indused osteoporosis: an apdate on effects and management. J. Allergy Clin. Immunol. 2013;132:1019-30.
- Ferguson A.S., van Bever H.P., Teper A.M., Lasytsya O., Goldfrad C.H., Whitehead P.J. A comparison of the relative growth velocities with budesonide and fluticasonr propionate in children with asthma. Respir. Med. 2007;101:118-29.
- Kelly H.W., Nelson H.S. Potential adverse effects of the inhaled corticosteroids. Allergy Clin. Immunol. 2003;112(3):469-68.
- Keiser H. Praxis der Cortisontherapie. Urban und Schwarzenberg, 1992. 96 p.
Supplementary files
